2022, Vol. 4, Issue 2, Part A

Aim: To improve medication adherence in hypertensive patients.

Methods and Materials: This cross-sectional observational research was conducted among participants with hypertension who had been on therapy for the previous 12 months were recruited for the trial after providing written informed permission. A full history was obtained, and the subjects were subjected to a thorough clinical evaluation, as well as counselling for lifestyle changes. The patients were given the MO risky Medication Adherence Scale-8 (MMAS-8) and WHO-QOL Brief questionnaires, and they were given time to complete them in a separate room away from the treating physician.

Results: The average age of the patients was 53.98±10.78 years, the average number of medications taken per individual was 1.82±0.79, and 74% of the patients were using a combination of pharmaceuticals for hypertension. The mean MMAS-8 Score of 4.52±1.22 and the mean WHO-QOL Brief Scores. The mean duration of illness in Group 1 was substantially (p0.05) smaller than in Group 2 (4.41±2.52 years vs. 5.51±2.81 years), and the MMAS-8 scores in Group 1 were significantly (p<0.05) higher (4.81±1.42 vs. 3.79±0.76) — patients in Group 1 were more adherent to treatment than patients in Group 2. Group 1 had better scores in three domains: physical health (12.12±1.42 vs. 12.11±1.42), social connection (13.54±4.25 vs. 12.89±4.52), and environment (12.02±1.28 vs. 12.06±1.47), but Group 2 had higher scores in one domain: psychological (13.11±2.36 vs. 12.95±2.41). Because the surveys were only to be filled out by patients, there was a risk of interpretation bias based on the patients' comprehension.

Conclusion: To summarise, patients had a poor adherence score, which was considerably lower in patients who were taking two or more drugs in combination or as a single component